• OPEN AN ACCOUNT
Indian Indices
Sensex
83,021.75 989.94
( 1.21%)
Global Indices
Nasdaq
50,205.66 -574.76
(-1.13%)
Dow Jones
7,342.05 -19.48
(-0.26%)
Hang Seng
59,472.71 448.43
(0.76%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.54 -0.42
(-0.44%)
EUR-INR
102.90 -0.55
(-0.53%)
GBP-INR
123.45 -0.54
(-0.44%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Ajanta Pharma consolidated net profit rises 49.18% in the September 2026 quarter
Oct 30,2026
Net profit of Ajanta Pharma rose 49.18% to Rs 388.14 crore in the quarter ended September 2026 as against Rs 260.19 crore during the previous quarter ended September 2025. Sales rose 32.53% to Rs 1794.16 crore in the quarter ended September 2026 as against Rs 1353.73 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales1794.161353.73 33
OPM %30.5224.22 -
PBDT582.71383.78 52
PBT535.15340.81 57
NP388.14260.19 49